PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc. a leading provider of the end-to-end platform for digitally enabled and data-driven clinical trials, today announced it has been awarded two Fast-Track Small Business Innovation (SBIR) grants from the National Cancer Institute (NCI). The grants will provide up to $3.5 million in nondilutive research funding over the next several years.
Medable Awarded $3.5M in SBIR Fast-Track Grants from the National Cancer Institute to Develop Digital Platforms to Improve Patient Care